{"id":"NCT01033071","sponsor":"Takeda","briefTitle":"Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.","officialTitle":"A Phase 3b, Double-Blind, Randomized, 12-Week Efficacy and Safety Study Comparing the TAK-491 Plus Chlorthalidone Fixed-Dose Combination vs Olmesartan Medoxomil-Hydrochlorothiazide in Subjects With Moderate to Severe Hypertension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-01","primaryCompletion":"2010-10","completion":"2010-11","firstPosted":"2009-12-16","resultsPosted":"2012-02-07","lastUpdate":"2012-02-07"},"enrollment":1071,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Essential Hypertension"],"interventions":[{"type":"DRUG","name":"Azilsartan medoxomil and chlorthalidone","otherNames":["azilsartan medoxomil plus chlorthalidone","TAK-491CLD"]},{"type":"DRUG","name":"Azilsartan medoxomil and chlorthalidone","otherNames":["azilsartan medoxomil plus chlorthalidone","TAK-491CLD"]},{"type":"DRUG","name":"Olmesartan medoxomil and hydrochlorothiazide","otherNames":["Benicar HCTÂ®"]}],"arms":[{"label":"Azilsartan Medoxomil 20-40mg/Chlorthalidone 12.5-25mg QD","type":"EXPERIMENTAL"},{"label":"Azilsartan Medoxomil 40-80mg/Chlorthalidone 12.5-25mg QD","type":"EXPERIMENTAL"},{"label":"Olmesartan Medoxomil 20-40mg/Hydrochlorothiazide 12.5-25mg QD","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the antihypertensive effect of azilsartan medoxomil plus chlorthalidone, once daily (QD), to olmesartan medoxomil plus hydrochlorothiazide in participants with moderate to severe hypertension.","primaryOutcome":{"measure":"Change From Baseline in Trough, Sitting, Clinic Systolic Blood Pressure.","timeFrame":"Baseline and Week 12.","effectByArm":[{"arm":"Azilsartan Medoxomil 20-40mg/Chlorthalidone 12.5-25mg QD","deltaMin":-42.5,"sd":0.81},{"arm":"Azilsartan Medoxomil 40-80mg/Chlorthalidone 12.5-25mg QD","deltaMin":-44,"sd":0.83},{"arm":"Olmesartan Medoxomil 20-40mg/Hydrochlorothiazide 12.5-25mg QD","deltaMin":-37.1,"sd":0.8}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":94,"countries":["United States","Canada"]},"refs":{"pmids":["22710649"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":355},"commonTop":["Blood creatinine increased","Dizziness","Fatigue","Headache","Blood uric acid increased"]}}